Lurasidone compared with placebo and haloperidol for schizophrenia
About this title
Read the official source — NCT00044044Researchers compared Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg and placebo, tracking side effects to assess safety in people with schizophrenia.
Understand this study
What did researchers investigate?
Researchers compared Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg and placebo, tracking side effects to assess safety in people with schizophrenia.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.
- Listed locations
- Birmingham and 33 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 356
- Sponsor
- Sumitomo Pharma America, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT00044044
- Official title
Show the full official title
A 6-Week, Double-Blind, Randomized, Fixed-Dose, Parallel-Group Study of the Efficacy and Safety of Three Dose Levels of SM-13496 Compared to Placebo and Haloperidol in Patients With Schizophrenia Who Are Experiencing an Acute Exacerbation of Symptoms
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Birmingham · Cerritos · Garden Grove
26 more locations
- Glendale
- La Mesa
- Orange
- San Diego
- Washington D.C.
- Melbourne
- North Miami
- Tampa
- Winter Park
- Atlanta
- Smyrna
- Honolulu
- Hoffman Estates
- Oak Brook
- Rockville
- North Las Vegas
- Clementon
- Kenilworth
- Cincinnati
- Philadelphia
- Austin
- Bellaire
- Dallas
- Falls Church
- Belleview
- Milwaukee
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg and placebo, tracking side effects to assess safety in people with schizophrenia.
Who is behind this study?
The study sponsor is Sumitomo Pharma America, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg and Placebo.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.
